Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diller, L.
Right arrow Articles by Li, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diller, L.
Right arrow Articles by Li, F. P.

Journal of Clinical Oncology, Vol 16, 3634-3640, Copyright © 1998 by American Society of Clinical Oncology


ARTICLES

Constitutional WT1 mutations in Wilms' tumor patients

L Diller, M Ghahremani, J Morgan, P Grundy, C Reeves, N Breslow, D Green, D Neuberg, J Pelletier and FP Li
Dana-Farber Cancer Institute, Boston, MA 02115, USA. lisa_diller@dfci.harvard.edu

PURPOSE: Patients with Wilms' tumors (WT) who carry constitutional mutations in the WT1 gene have been described in case reports and small case series. We sought to determine the frequency of constitutional WT1 mutations in a larger cohort, and to identify clinical manifestations associated with the risk for carrying a WT1 mutation. METHODS: We collected clinical data and blood samples from 201 patients with a history of WT. Southern blot analysis, single-strand conformation polymorphism (SSCP) analysis, and direct DNA sequencing were performed on DNA isolated from peripheral-blood lymphocytes from each patient. Odds ratios (ORs) for the carriage of a germline mutation of the WT1 gene were calculated for patients who had specific clinical risk factors compared with those who did not. RESULTS: Of 201 patients with WT in the cohort, eight patients were carriers of mutations in the WT1 gene. Six of the eight mutations were protein-truncating nonsense mutations. None of 56 patients with isolated unilateral WT was a carrier. The OR of carrying a WT1 mutation was elevated for patients with genitourinary anomalies (OR19.3; P < .002). Seven of 28 boys with WT with cryptorchidism carried WT1 mutations. No increased risk was observed for patients with nephrogenic rests, bilateral tumors, history of secondary cancers, or family history of WT. CONCLUSION: Germline WT1 mutations in patients with WT are associated with genitourinary anomalies, especially cryptorchidism and/or hypospadias. Patients with WT and no genitourinary anomalies are at low risk for carrying a WT1 mutation. Constitutional WT1 mutations that encode truncated WT1 proteins may predispose to the development of cryptorchidism, hypospadias, and WTs.


This article has been cited by other articles:


Home page
JCOHome page
S. E. Little, S. P. Hanks, L. King-Underwood, C. Jones, E. A. Rapley, N. Rahman, and K. Pritchard-Jones
Frequency and Heritability of WT1 Mutations in Nonsyndromic Wilms' Tumor Patients: A UK Children's Cancer Study Group Study
J. Clin. Oncol., October 15, 2004; 22(20): 4140 - 4146.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
K Pritchard-Jones
Controversies and advances in the management of Wilms' tumour
Arch. Dis. Child., September 1, 2002; 87(3): 241 - 244.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. J. Richard, V. Schumacher, B. Royer-Pokora, and S. G.E. Roberts
Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1
Genes & Dev., February 1, 2001; 15(3): 328 - 339.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
K. PRITCHARD-JONES, N. RAHMAN, M. GERRARD, D. VARIEND, and L. KING-UNDERWOOD
Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity
J. Med. Genet., May 1, 2000; 37(5): 377 - 380.
[Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1998 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online